|
【参考文献】
1 Mannello F, Tonti G, Papa S, et al. Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr Cancer Drug Targets 2005;5:285298
2 Parks WC, Wilson CL, LopezBoado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617629
3 Steffensen B, Hakkinen L, Larjava H. Proteolytic events of woundhealingcoordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Critical Reviews in Oral Biology & Medicine 2001;12(5):373398
4 Khasigov PZ, Podobed OV, Graeheva TS, et al. Role of matrix metallop roteinases and their inhibitors in tumor invasion and metastasis. Biochemistry 2003;68 (7):711717
5 Fu XY, Parks WC, Jay W, et al. Activation and silencing of matrix metalloproteinases. Seminars in Cell & Developmental Biology 2008;19:213
6 Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrixmetall oproteinases and their tissue inhibitors at the advancing pterygium head. In vest Ophthalmol Vis Sci 2000;41:41424149
7 Di Girolamo N, Lloyd A, McCluskey P, et al. Increased expression of matrixmetalloproteinases in vivo in scleritis tissue and invitro in cultured humans cleral fibroblasts. Am J Pathol 1997;150(2):653666
8 Jones BE, Thompson EW, Hodos W, et al. Scleral matrix metalloproteinases, serine proteinase activity and hydrational capcity are increased in myopia induced by retinal imgae degradation. Exp Eye Res 1996;63:369381
9 Kenning MS, GetleA, McBrien NA. Expression and cDNA sequence of Matrix metalloproteinase2 in a mammalian model of human disesase processes: Tupaia belangeri. DNA Seq 2004;15:332337
10 Thiennu HV. Matrix metalloproteinases effecrors of development and normal physiology. Genes Dev 2000;14(17):2123
11 Shi QC, Ning JH. Restrained effect of GM6001 the tissue inhibitor of matrix metalloproteinases on the growth of rats corneal neovascularization after alkaline burn. Int J Ophthalmol(Guoji Yanke Zazhi) 2008;8(3):496498
12于长江,段穆,洪晶. 热烧伤后的人角膜组织中基质金属蛋白酶2、9表达的研究.国际眼科杂志 2008; 8(9):17731776
13 Moses MA. The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cell 1997;15:180189
14 Takahashi H, Akiba K, Noguchi T, et al. Matrix metalloproteinase activity is enhanced during corneal wound repair in high gluose condition. Curr Eye Res 2000;21(2):608615
15 Smith VA, Rishawi H, Hussein H, et al. Tear film MMP accumulation and corneal disease. Br J Ophthalmol 2001;85(2):147153
16 Solomon A, Dursun D, Liu Z, et al. Pro and antiinflammatory forms of interleukin in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci 2001;42(10):22832292
17 Paterson CA, Well JG, Koklitis PA, et al. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkaliburnindueed corneal ulceration in rabbits. Invest Ophthalmol Vis Sci 1994;35:677684
18李钫, 邢怡桥, 杨燕宁.羊膜移植对实验性单疱病毒角膜炎中MMP9及TIMP1 表达的影响 眼科新进展 2005;25(3):236239
19徐国兴, 胡建章, 郑卫东,等.基质金属蛋白酶2和金属蛋白酶2组织抑制因子及转化生长因子β在糖尿病性白内障患者晶状体上皮细胞的表达及意义 中华眼科杂志 2003;39(7):411414
20 Tarniya S, Wormstone IM, Marcantonio JM, et al. Induction of matrix metallproteinases2 and 9 following stress to the lens. Exp Eye Ras 2000;71(6):591597
21 Wormstone IM, Tamiya S, An derson I, et al. TGFbeta2 induced matrix modification and cell trans differentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002;43(7):23012308
22 Kawashima Y, Saika S, Miyamoto T, et al. Matrix metalloproteinases and tissue inhibitors of matalloproteineses of fibrous humans lens capsules with intraocular leuses. Curr Eye Res 2000;21:962967
23金明,吴景天.体外培养猴眼小梁细胞及睫状肌细胞中组织金属蛋白酶抑制剂的表达.中华眼科杂志 2002;38:298301
24 Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nervehead. J Neurosci Res 2001;64(5):523532
25张佳莹，冷菲，彭绍民.抗青光眼眼表药物与人结膜成纤维细胞TGFβ、MMP的表达.国际眼科杂志 2007;7(5):12941297
26 Cuello C, Wakefield D, Di Girolamo N. Neutrophil accumulation correlates with type Ⅳcollagenase/ gelatinase activity in endoxin induced uveitis. Br J Ophthalmol 2002;86(3):290295
27 ElShabrawi YG, Christen WG, Foster SC. Correlation of metalloproteinas 2 and 9 with proinflammatory cytokines interleukin1b, interleukin12 and the interleukin1 receptor antagonist inpatients with chronic uveitis. Curr Eye Res 2000;20(3):211214
28 Wallace GR, Whiston RA, Stanford MR, et al. The matrix metalloproteinase inhibitor BB1101 prevent sex perimental autoimmune uveoretinitis ( EAU). Clin Exp Immunol 1999;118 (3):364370
29 Vaughan Thomas A, Gillbert SJ, Duance VC. Elevated levels of proteolytic enzymes in the aginghuman vitreous. Invest Ophthalmol Vis Sci 2000;41(11):32993304
30 Kon CH, Occleston NL, Charteris D, et al. A prospective study of matrixmetalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998;39(8):15241529
31王桂云,左玲,李旭,等.基质金属蛋白酶2、9 含量表达与孔源性视网膜脱离相关性研究.中国老年学杂志 2006;26:16261627
32 Chantrain CF, Henriet P, Jodele S, et al. Mechanism s of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases. Euro J Cancer 2006;42(3):310318
33 Descamps FJ, Martens E, Kangave D, et al. The activated form of gelatinase B /matrix metalloproteinase9 is associated with diabetic vitreous hemorrhage. Exp Eye Res 2006;83(2):401407
34刘东宁，刘哲丽.增殖性糖尿病视网膜病变基质金属蛋白酶的表达.国际眼科杂志 2007;7(3):682684
35彭惠,洪苏玲,陶永贤,等.基质金属蛋白酶MMP2mRNA在糖尿病苍鼠视网膜中的表达.第四军医大学学报 2006;27(17):15701572
36 Lambert V, Wielockx B, Munaut C, et al. MMP2and MMP9 synergize in promoting choroidal neovascularization. FASEB J 2003;17(15):2290 2292
37 Leu ST, Batni S, RadekeMJ, et al. Drunsen are cold sports for proteolysis: Expression of trixmetauop roteies and their tissue inhibitor proteins in agerelated macu1ar degeneration. Exp Eye Res 2002;74(1):141154
38 StetlerStevenson WG, Seo DW. TIMP2: a endogenous inhibitor of angiogenesis. Trends Mol Med 2005; 11(3):97103
39 Jonas JB, Kreissig I, Hugger P, et al. Intravitreal triamcinolone acetonide for exudative age relatedmacular degeneration. Br J Ophthalmol 2003;87(4):462468
40龙华, 姜发纲.MMP2和MMP9在视网膜母细胞瘤中的表达及意义.眼科新进展 2006;26(12):908910
41葛蓁, 李玉军,刘波.MMP9、TIMP1和VEGF在视网膜母细胞瘤中的表达及意义.山东医药 2007;47(19):5355
42吴继红, 徐萍, 易苗英, 等.体外培养的人视网膜母细胞瘤细胞株及其肿瘤血管生成相关因子表达的实验研究.中华眼科杂志 2005;41(5):419422
43陈陆霞,张诗武,孙保存,等.MMP2、MMP9的表达与脉络膜黑色素瘤微血管密度及肿瘤转移的关系.眼科新进展 2007;27(8):565567
上一页 [1] [2] |
